优化 12 个东欧和中亚国家的艾滋病毒支出:建模研究。
Optimising HIV spending in 12 eastern European and central Asian countries: a modelling study.
机构信息
Burnet Institute, Melbourne, VIC, Australia.
Burnet Institute, Melbourne, VIC, Australia.
出版信息
Lancet HIV. 2024 Oct;11(10):e690-e699. doi: 10.1016/S2352-3018(24)00188-7. Epub 2024 Sep 5.
BACKGROUND
The eastern European and central Asian (EECA) region has the fastest growing HIV epidemic globally. We aimed to identify how HIV resources could be allocated for maximum health impact.
METHODS
Between Aug 1 and Dec 23, 2022, allocative efficiency analyses were undertaken for 12 countries in the EECA region (Albania, Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kosovo, Kyrgyzstan, Moldova, Serbia, Tajikistan, and Uzbekistan) using HIV epidemic models developed with Optima HIV. Country models were calibrated to demographic, epidemiological, and programmatic data and validated by national teams. Three scenarios were projected from 2023 to 2030: status quo (continued 2021 spending on HIV programmes); optimised allocation of different spending envelopes to minimise HIV infections and deaths; and achieving 95-95-95 UNAIDS targets by 2030.
FINDINGS
Aggregated across the 12 models, HIV infections attributable to sexual transmission were estimated to surpass those attributable to transmission through injecting drugs in 2018, with male-to-male sexual transmission accounting for a continuously increasing share. In the status quo scenario, there were an estimated 111 520 (95% CI 28 960-208 270) new HIV infections and 34 530 (17 280-57 410) HIV-related deaths between 2023 and 2030. Aggregated optimisation results suggest that 35 860 (32%) of 111 520 new HIV infections and 9170 (27%) of 34 530 HIV-related deaths could be averted from 2023 to 2030 compared with the status quo, by prioritising antiretroviral therapy and targeted key population programmes. For ten countries, achieving 95% diagnosis was projected to not be possible with the current budget envelope, and for seven countries, this target could require more than three times the current spending. Compared with the status quo, achieving 95-95-95, or as close as possible, could avert 70 880 (64%) of 111 520 new HIV infections and 18 890 (55%) of 34 530 HIV-related deaths from 2023 to 2030.
INTERPRETATION
Targeted key population programmes should remain high priorities in the EECA region. Achieving 95-95-95 will require more emphasis on implementing appropriate modes of service delivery that reduce the gap in diagnosis and treatment coverage for people living with HIV.
FUNDING
The Global Fund to Fight AIDS, Tuberculosis and Malaria.
TRANSLATION
For the Russian translation of the summary see Supplementary Materials section.
背景
东欧和中亚(EECA)地区是全球艾滋病毒流行增长最快的地区。我们旨在确定如何分配艾滋病毒资源以实现最大的健康影响。
方法
在 2022 年 8 月 1 日至 12 月 23 日期间,使用 Optima HIV 开发的艾滋病毒流行模型,对 EECA 地区的 12 个国家(阿尔巴尼亚、亚美尼亚、阿塞拜疆、白俄罗斯、格鲁吉亚、哈萨克斯坦、科索沃、吉尔吉斯斯坦、摩尔多瓦、塞尔维亚、塔吉克斯坦和乌兹别克斯坦)进行了分配效率分析。国家模型根据人口、流行病学和方案数据进行了校准,并由国家团队进行了验证。从 2023 年到 2030 年,预计有三种情景:现状(继续 2021 年用于艾滋病毒规划的支出);优化不同支出范围的分配,以最大程度地减少艾滋病毒感染和死亡;并在 2030 年前实现 95-95-95 的艾滋病规划署目标。
发现
在 12 个模型的综合分析中,据估计,性传播导致的艾滋病毒感染将在 2018 年超过注射吸毒传播导致的感染,而男男性传播导致的感染比例持续增加。在现状情景下,预计 2023 年至 2030 年间将有 111520 例(95%CI28960-208270)新艾滋病毒感染和 34530 例(17280-57410)艾滋病毒相关死亡。综合优化结果表明,与现状相比,通过优先考虑抗逆转录病毒疗法和有针对性的重点人群方案,2023 年至 2030 年间,可避免 35860 例(32%)新艾滋病毒感染和 9170 例(27%)艾滋病毒相关死亡。在十个国家,预计目前的预算范围不可能实现 95%的诊断,而在七个国家,实现这一目标可能需要目前支出的三倍以上。与现状相比,实现 95-95-95 或尽可能接近这一目标,可避免 2023 年至 2030 年间 111520 例新艾滋病毒感染中的 70880 例(64%)和 34530 例艾滋病毒相关死亡中的 18890 例(55%)。
解释
有针对性的重点人群方案应继续成为 EECA 地区的高度优先事项。要实现 95-95-95,就需要更加重视实施适当的服务提供模式,缩小艾滋病毒感染者诊断和治疗覆盖率方面的差距。
资金来源
全球抗击艾滋病、结核病和疟疾基金。